Market Closed -
Nasdaq
21:30:01 03/05/2024 BST
|
5-day change
|
1st Jan Change
|
22.05
USD
|
-0.05%
|
|
-1.30%
|
-2.04%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
89.54
|
238.4
|
1,749
|
1,233
|
949.3
|
953.6
|
-
|
-
|
Enterprise Value (EV)
1 |
89.54
|
238.4
|
1,749
|
1,233
|
949.3
|
953.6
|
953.6
|
953.6
|
P/E ratio
|
-19.3
x
|
-28.4
x
|
-53.3
x
|
-15.5
x
|
-9.7
x
|
-10.3
x
|
-46.4
x
|
-7.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
6.36
x
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
6.36
x
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-33,366,415
x
|
-15,363,989
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
17,219
|
34,954
|
40,017
|
41,726
|
42,174
|
43,246
|
-
|
-
|
Reference price
2 |
5.200
|
6.820
|
43.70
|
29.54
|
22.51
|
22.05
|
22.05
|
22.05
|
Announcement Date
|
26/03/20
|
23/03/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
150
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-4.959
|
-6.446
|
-32.87
|
-80.02
|
-106
|
-104.6
|
10.75
|
-148.4
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
7.17%
|
-
|
Earnings before Tax (EBT)
1 |
-4.631
|
-6.334
|
-32.38
|
-76.25
|
-97.22
|
-96.6
|
18.85
|
-139.6
|
Net income
1 |
-4.631
|
-6.334
|
-32.38
|
-76.25
|
-97.22
|
-96.6
|
-0.1
|
-139.6
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.07%
|
-
|
EPS
2 |
-0.2700
|
-0.2400
|
-0.8200
|
-1.900
|
-2.320
|
-2.145
|
-0.4750
|
-2.940
|
Free Cash Flow
|
-
|
-
|
-52.41
|
-80.23
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/03/20
|
23/03/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-9.753
|
-14.44
|
-17.82
|
-19.92
|
-21.34
|
-20.94
|
-26.51
|
-28.78
|
-27.88
|
-22.79
|
-21.8
|
-21.6
|
-23.2
|
-25.45
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-9.562
|
-14.17
|
-17.53
|
-19.33
|
-20.26
|
-19.13
|
-24.27
|
-26.38
|
-25.65
|
-20.92
|
-19.75
|
-19.45
|
-21.15
|
-23.4
|
Net income
1 |
-9.562
|
-14.17
|
-17.53
|
-19.33
|
-20.26
|
-19.13
|
-24.27
|
-26.38
|
-25.65
|
-20.92
|
-19.75
|
-19.45
|
-21.15
|
-23.4
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.2400
|
-0.3500
|
-0.4400
|
-0.4800
|
-0.5100
|
-0.4700
|
-0.5800
|
-0.6300
|
-0.6100
|
-0.5000
|
-0.4600
|
-0.4500
|
-0.4850
|
-0.4600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/11/21
|
28/02/22
|
05/05/22
|
04/08/22
|
07/11/22
|
28/02/23
|
01/05/23
|
03/08/23
|
07/11/23
|
28/02/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-52.4
|
-80.2
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
22.2
|
2.71
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/03/20
|
23/03/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Last Close Price
22.05
USD Average target price
99.5
USD Spread / Average Target +351.25% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.04% | 954M | | +8.96% | 105B | | -1.43% | 104B | | +4.40% | 22.94B | | -12.15% | 22.34B | | -4.36% | 19.25B | | -39.98% | 17.08B | | -10.04% | 16.96B | | +6.79% | 14.16B | | +38.61% | 12.63B |
Bio Therapeutic Drugs
|